Respiratory Drugs
The landscape of respiratory pharmacology is broad, spanning from the management of chronic conditions like asthma and COPD to the treatment of acute pulmonary infections. The cornerstone of therapy remains the delivery system, as the efficacy of these medications is inherently tied to their ability to reach the distal airways. Bronchodilators, including beta-agonists and anticholinergics, serve as the primary line of defense to alleviate airflow obstruction. Meanwhile, inhaled corticosteroids act as the essential preventative measure, dampening the underlying inflammation that drives airway hyperresponsiveness. The shift toward "MART" (Maintenance and Reliever Therapy) protocols highlights a more dynamic approach to patient management, allowing individuals to adjust their dosage based on immediate symptomatic needs.